NCMP-13. BRAIN MRI FINDINGS IN PATIENTS TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) DURING SEVERE NEUROTOXICITY

INTRODUCTION: Severe neurotoxicity occurs in ~30% of Diffuse Large B Cell Lymphoma (DLBCL) patients treated with CAR-T cell therapy. Brain MRI is used to assess and manage patients during neurotoxicity. Brain MRI can help understand which brain locations are affected during neurotoxicity. However, i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Mokhtari, Sepideh, Arrington, John, Asquith, Justin, Bachmeier, Christina, Locke, Frederick, Lazaryan, Aleksandr
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Neurological Complications of Cancer and Cancer Therapy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847810/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.759
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky